Panos Roussos received his medical and doctorate degrees from the University of Crete in Greece. He completed his residency in Psychiatry (research track) at Icahn School of Medicine at Mount Sinai followed by a MIRECC research fellowship in schizophrenia.
Language
English
Position
PROFESSOR | Genetics and Genomic Sciences, PROFESSOR | Psychiatry, PROFESSOR | Artificial Intelligence and Human Health
Panos Roussos received his medical and doctorate degrees from the University of Crete in Greece. He completed his residency in Psychiatry (research track) at Icahn School of Medicine at Mount Sinai followed by a MIRECC research fellowship in schizophrenia.
Language
English
Position
PROFESSOR | Genetics and Genomic Sciences, PROFESSOR | Psychiatry, PROFESSOR | Artificial Intelligence and Human Health
Genetics and Genomic Sciences [GGS], Neuroscience [NEU]
Education
MD, University of Crete
MD, University of Crete
MS, University of Crete
PhD, University of Crete
Residency, Icahn School of Medicine at Mount Sinai
Residency, Psychiatry
Mount Sinai Hospital
Awards
2020
Eva King Killam Research Award
American College of Neuropsychopharmacology
2019
Scientific Award in Life Sciences (Biomedical Sciences)
Bodossakis Foundation
2019
Rising Star Award, Rising Star Award
Congress of the Schizophrenia International Research Society
2016
Presidential Early Career Awards for Scientists and Engineers
White House
2013
Young Investor Award
NARSAD
2012
Early Academic Career Award
APA/Merck
2010
Outstanding Resident Award
National Institute of Mental Health
Research
Panos Roussos's research is focused on precision psychiatry by identifying the genetic variants and underlying mechanisms that cause disease and, ultimately, enabling personalized therapy.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Roussos did not report having any of the following types of financial relationships with industry and other outside entities during 2024 and/or 2025: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Roussos did not report having any of the following types of financial relationships with industry and other outside entities during 2024 and/or 2025: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Mount Sinai Doctors